Fig. 3From: H19 overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemiaPrognostic value of H19 expression on overall survival in AML using TCGA and GEO data. a–c The impact of H19 expression on overall survival (OS) in a cohort of 200 AML patients from The Cancer Genome Atlas (TCGA) databases. The patients were classified into H19 low-expressed and high-expressed groups by the median level of ID4 expression. a OS among whole-cohort AML. b OS among non-APL-AML. c OS among cytogenetically normal AML (CN-AML). d–g The impact of H19 expression on OS in two independent cohorts of 78 and 162 CN-AML patients were obtained from Gene Expression Omnibus (GEO) data. Survival analysis was performed through the online web tool Genomicscape. d Probe 224646_at among a cohort of 78 CN-AML patients. e Probe 224997_at among a cohort of 78 CN-AML patients. f Probe 224646_at a cohort of 162 CN-AML patients. g Probe 224997_at among a cohort of 162 CN-AML patientsBack to article page